Company Profile

Fyodor Biotechnologies Inc
Profile last edited on: 11/23/16      CAGE: 536A2      UEI: JNEVR7AQJJF4

Business Identifier: Developing diagnostics for the diagnosis and treatment of infectious diseases, particularly malaria
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

800 West Baltimore Street Suite 408
Baltimore, MD 21201
   (443) 552-0437
Location: Single
Congr. District: 07
County: Baltimore City

Public Profile

Fyodor Biotechnologies Corporation is focused on the research, development and manufacturing and commercialization of innovative diagnostic and biopharmaceutical products, targeted to large emerging economies in Africa, Asia and South America. Diseases such as malaria, sleeping sickness, meningitis and typhoid fever are leading causes of morbidities and deaths in most emerging economies around the world. The most pronounced challenges in controlling these diseases is the limited availability and access to accurate, rapid, point-of-care diagnostic tools and sustained effective treatment. The firm's goal is to expand the availability and affordability of rapid diagnostics and pharmaceuticals against infectious diseases, with an initial focus on malaria.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Eddy C Agbo -- Chairman; Chief Executive Officer

  Anne M Derrick -- Vice President of Business Development & Operations

Company News

There are no news available.